Lipoprotein(a) in Pediatric Type 1 Diabetes: The Role of Pubertal Maturation Beyond Glycemic Control – A retrospective cross-sectional study

Abstract Background and Aims: Children and adolescents with type 1 diabetes (T1D) are at increased lifetime risk of cardiovascular disease (CVD). Lipoprotein(a) [Lp(a)] is an inherited CVD risk factor, but data in pediatric T1D are limited. We assessed Lp(a) concentrations, the prevalence of elevated Lp(a), and their associations with clinical characteristics, lipid profile, and pubertal maturation. Methods This retrospective, cross-sectional study included 516 children and adolescents (0–18 years) with T1D. Serum Lp(a) was measured by particle-enhanced immunoturbidimetric assay. Elevated Lp(a) was defined as ≥ 50 mg/dL. Associations with clinical variables, lipid parameters, and Tanner stage were evaluated using non-parametric tests and multivariable analysis. Results Median Lp(a) concentration was 8.0 mg/dL, and elevated Lp(a) was found in 66 patients (12.8%). Lp(a) was not associated with diabetes duration, HbA1c, new-onset diabetes, or diabetic ketoacidosis. Weak positive correlations were observed with LDL-C ( r s =0.259, p < 0.001) and non-HDL-C ( r s =0.264, p < 0.001). Lp(a) increased across Tanner stages, and the prevalence of elevated Lp(a) rose from 7.0% in stage 1 to 19.8% in stage 5. Tanner stage remained independently associated with Lp(a) after adjustment for sex, HbA1c, and LDL-C. Conclusions Elevated Lp(a) was common in pediatric T1D and increased with pubertal maturation. These findings suggest that pubertal stage should be considered when interpreting Lp(a) concentrations. Longitudinal studies are needed to determine the clinical value of Lp(a) in cardiovascular risk assessment.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11561944/v1
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Lipoprotein(a) in Pediatric Type 1 Diabetes: The Role of Pubertal Maturation Beyond Glycemic Control – A retrospective cross-sectional study

Małgorzata Myśliwiec, Anna Wołoszyn‐Durkiewicz, Maciej Banach, Patrycja Rozwadowska et al.
3 links
Research Square
Diabetes, Cardiovascular Risks, and Lipoproteins
preprint

Lipoprotein(a) in Pediatric Type 1 Diabetes: The Role of Pubertal Maturation Beyond Glycemic Control – A retrospective cross-sectional study

Małgorzata Myśliwiec, Anna Wołoszyn‐Durkiewicz, Maciej Banach, Patrycja Rozwadowska, Mateusz Okonek, Gabriela Gawlak
preprint en

Abstract

Abstract Background and Aims: Children and adolescents with type 1 diabetes (T1D) are at increased lifetime risk of cardiovascular disease (CVD). Lipoprotein(a) [Lp(a)] is an inherited CVD risk factor, but data in pediatric T1D are limited. We assessed Lp(a) concentrations, the prevalence of elevated Lp(a), and their associations with clinical characteristics, lipid profile, and pubertal maturation. Methods This retrospective, cross-sectional study included 516 children and adolescents (0–18 years) with T1D. Serum Lp(a) was measured by particle-enhanced immunoturbidimetric assay. Elevated Lp(a) was defined as ≥ 50 mg/dL. Associations with clinical variables, lipid parameters, and Tanner stage were evaluated using non-parametric tests and multivariable analysis. Results Median Lp(a) concentration was 8.0 mg/dL, and elevated Lp(a) was found in 66 patients (12.8%). Lp(a) was not associated with diabetes duration, HbA1c, new-onset diabetes, or diabetic ketoacidosis. Weak positive correlations were observed with LDL-C ( r s =0.259, p < 0.001) and non-HDL-C ( r s =0.264, p < 0.001). Lp(a) increased across Tanner stages, and the prevalence of elevated Lp(a) rose from 7.0% in stage 1 to 19.8% in stage 5. Tanner stage remained independently associated with Lp(a) after adjustment for sex, HbA1c, and LDL-C. Conclusions Elevated Lp(a) was common in pediatric T1D and increased with pubertal maturation. These findings suggest that pubertal stage should be considered when interpreting Lp(a) concentrations. Longitudinal studies are needed to determine the clinical value of Lp(a) in cardiovascular risk assessment.

Research Square
Medical University of Lodz (PL), Gdańsk Medical University (PL)
Good health and well-being
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon